Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats

Diabetes, Obesity and Metabolism

Volumn 5, Issue 6, 2003, Pages 455-461

  Ramachandran, B ^a   Kandaswamy, M ^a   Narayanan, V ^a   Subramanian, Subbus ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Insulin mimetic; Macrocyclic vanadium; Streptozotocin diabetes

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN; MACROCYCLIC COMPOUND; STREPTOZOCIN; UREA; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; LIVER METABOLISM; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

EID: 0345328751     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00302.x     Document Type: Article

References (39)

1. Pradeepa R, Deepa R, Mohan V. Epidemiology of diabetes in India - Current perspective and future projections. J Indian Med Assoc 2002; 100: 144-148.
2. Williams G. Management of non-insulin diabetes mellitus. Lancet 1994; 343: 95-100.
3. Dubyak GR, Kleinzeller AD. The insulin mimetic effects of vanadate in isolated rat adipocytes. J Biol Chem 1980; 255: 5306-5312.
4. Sakurai H, Tsuchiya K, Nukatsuka M, Sofue M, Kawada J. Insulin-like effect of vanadyl ion on streptozotocin diabetic rats. J Endocrinol 1990; 124: 451-459.
5. Heyliger EC, Tahiliani GA, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 1985; 227: 1474-1477.
6. Swarup G, Speeg KV, Cohen S, Garbers DL. Phopshotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem 1982; 257: 7298-7301.
7. Ramanandham S, Mongold JJ, Brownsey RW, Cors GH, McNeill JH. Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 1989; 257: H904-H911.
8. McNeill JH, Yuen VG, Hoveyda HR, Chris O. Bis-(maltolato) oxovanadium (IV) is a potent insulin mimic. J Med Chem 1992; 35: 1489-1491.
9. Nandhini D, Maneemegalai S, Elangovan V, Sekar N, Govindasamy S. Insulin like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats. Indian J Biochem Biophys 1993; 30: 73-76.
10. V complexes: Synthesis, strucuture, electrochemistry and magnetochemistry. J Inorg Chem 1995; 34: 2861-2869.
11. Maneemegalai S, Sekar N, Govindasamy S. Insulin-like effect of sodium orthovanadate on urea cycle enzymes in streptozotocin diabetic rats. J Clin Biochem Nutr 1994; 16: 187-192.
12. Sasaki T, Matsy S, Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku 1972; 1: 346-353.
13. Natelson S, Scott ML, Begga E. A rapid method for the estimation of urea in biological fluids by means of the reaction between diacetyl and urea. Am J Clin Pathol 1951; 21: 275-281.
14. King J. In: Princeton MJ, ed. Practical Clinical Enzymology. London: Van D Wostrand Company, 1965; 363-395.
15. Brandstrup N, Kirk JE, Bruni C. Determination of hexokinase in tissues. J Gerontol 1957; 12: 166-171.
16. King J. Colorimetric determination of serum lactate dehydrogenase. J Med Lab Tech 1959; 16: 265-269.
17. Koide H, Oda T. Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin Chim Acta 1959; 4: 554-561.
18. Gancedo JM, Gancedo L. Fructose-1,6-bisphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeasts. Arch Mikrobiol 1971; 176: 132-138.
19. Cornblath M, Randle PJ, Parmeggiani A, Morgan HE. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 1963; 238: 1592-1597.
20. Ell HA, Kirkman HM. A colorimetric method for assay of erythrocytic glucose-6-phophate dehydrogenase. Proc Soc Exp Biol Med 1961; 106: 607-609.
21. Leloir LF, Goldenberg SH. In: Colowick SP, Kalpan NO, eds. Methods of Enzymology. New York: Academic Press 1979; V: 145-148.
22. Morales MA, Jabbagy AJ, Terenizi HR. Mutations affecting accumulation of Neurospora glycogen. News Lett 1973; 20: 24-25.
23. Sekar N, Kanthasamy S, William S, Subramanian S, Govindasamy S. Insulinic action of vanadate on experimental diabetes. Pharmacol Res 1990; 22: 207-217.
24. Sakurai H, Tsuchiya K, Nukatsuka M et al. Insulin-mimetic action of vanadyl complexes. J Clin Biochem Nutr 1990; 8: 193-200.
25. Meyerovitch J, Farfel Z, Sack J, Schecter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin treated rats. J Biol Chem 1987; 262: 6658-6662.
26. Spence TJ. Levels of translatable mRNA coding for rat liver glucokinase. J Biol Chem 1983; 258: 9143-9146.
27. Valera A, Rodriguez-Gil JE, Bosch F. Vanadate restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats. J Clin Invest 1993; 92: 4-11.
28. Nandhini D, Govindasamy S. Insulin-like effects of Bis-Salicylidine Ethylenediiminato oxovanadium (IV) complex on carbohydrate metabolism. J Clin Biochem Nutr 1997; 22: 31-39.
29. Nour-Eldeen AF, Craig MM, Gresser M. Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Non-enzymic formation of glucose-6-vanadate. J Biol Chem 1985; 260: 6836-6842.
30. Stefen L, Irwin F. Vanadate stimulates the oxidation of NADH. Free Radic Biol Med 1987; 1: 257-259.
31. Burchell A, Cain DI. Rat microsomal glucose-6-phophatase protein are increased in streptozotocin induced diabetes. Diabetologia 1985; 28: 852-856.
32. Meyerovitch J, Becker JM, Kahn CR. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J Clin Invest 1989; 84: 976-983.
33. Singh J, Nordlie RC, Jorgenson AR. Vanadate: a potent inhibitor of multifunctional glucose-6-phosphatase. Biochim Biophys Acta 1981; 678: 477-482.
34. Roesler JW, Khandelwal RL. Quantitation of glycogen synthase and phosphorylase protein mouse liver. Correlation between enzymatic protein and enzymatic activity. Arch Biochem Biophys 1986; 244: 397-407.
35. Tamura S, Brown TA, Whipple JH et al. A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 1984; 259: 6650-6658.
36. Morris G, Leon LM. Protein metabolism and protein synthesis in perfused livers of normal and alloxan diabetic rats. J Biol Chem 1960; 235: 3202-3208.
37. Hansen TV, Aaseth J, Alexander J. The effect of chelating agents on vanadium distribution in rat body and on uptake by human erythrocytes. Arch Toxicol 1982; 50: 195-198.
38. Jandhyala BS, Hom GJ. Physiological and pharmacological properties of vanadium. Life Sci 1983; 33: 1325-1331.
39. Rao GM, Morghom LO, Kabur MN, Ben Mohmud BM, Ashibani K. Serum glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) levels in diabetes mellitus. Indian J Med Sci 1989; 43: 118-121.